Literature DB >> 15076246

Seroepidemiology of HTLV-I/II in Argentina: an overview.

Rene Gastaldello1, William W Hall, Sandra Gallego.   

Abstract

In this report, the results of seroepidemiologic studies of human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II) infections in different population groups in Argentina have been compiled. The studies have shown a high prevalence of HTLV-I/II infection in blood donors in the provinces in the north of Argentina (1.0% in Jujuy, 0.7% in Salta, and 0.6% in Formosa) and a low prevalence in the provinces in the central region of the country (<or=0.1%). High rates of HTLV-I (0.45%-2.78%) and HTLV-II (2.78%-21.9%) infections have been documented in Native Indian groups and have highlighted the importance of sexual and mother-to-child transmission of the viruses. The presence of HTLV-I/II antibodies in HIV-infected individuals indicates that both viruses are circulating in certain high-risk population groups. HTLV-I/II was detected in intravenous drug users (2.56%-21.7%), homosexual men (0.5-1.33%), prostitutes (0.8%), and hemophiliacs (2.8%). In conclusion, HTLV-I/II infection is circulating in low- and high-risk populations in Argentina, and these findings would support the view that selective screening for HTLV-I/II should be implemented to reduce the spread of infection.

Entities:  

Mesh:

Year:  2004        PMID: 15076246     DOI: 10.1097/00126334-200403010-00012

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012).

Authors:  Gregorio González-Alcaide; José Manuel Ramos; Charles Huamaní; Carmen de Mendoza; Vicent Soriano
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-02-23       Impact factor: 1.846

2.  The Changing Epidemiology of Human T-Cell Lymphotropic Virus Type 1 Infection in Peruvian Female Sex Workers, 1993-2010.

Authors:  Jenell Stewart; Kristen Heitzinger; Simon Pollett; Martha Calderón; Jorge Alarcón; Thanh G N Ton; Joseph R Zunt
Journal:  Am J Trop Med Hyg       Date:  2016-11-22       Impact factor: 2.345

3.  Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile.

Authors:  Luis Chandía; Cristina Sotomayor; Sylvia Ordenes; Pilar Salas; Maritza Navarrete; Mauricio Lopez; Carola Otth
Journal:  Med Microbiol Immunol       Date:  2010-08-13       Impact factor: 3.402

4.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

Review 5.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

6.  Low Proviral Load is Associated with Indeterminate Western Blot Patterns in Human T-Cell Lymphotropic Virus Type 1 Infected Individuals: Could Punctual Mutations be Related?

Authors:  Camila Cánepa; Jimena Salido; Matías Ruggieri; Sindy Fraile; Gabriela Pataccini; Carolina Berini; Mirna Biglione
Journal:  Viruses       Date:  2015-10-28       Impact factor: 5.048

7.  Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission.

Authors:  María C Frutos; Rene Gastaldello; Marcos Balangero; Carlos Remondegui; Sebastián Blanco; Koko Otsuki; Ana Carolina Paulo Vicente; David Elías; Arnaldo Mangeaud; Silvia Nates; Sandra Gallego
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 8.  HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.

Authors:  Daniel Bradshaw; Graham Philip Taylor
Journal:  Front Med (Lausanne)       Date:  2022-04-29

9.  Making Visible HTLV Infection in a Non-endemic Area of Argentina.

Authors:  Federico R Simioli; Maria B Bouzas; Dana Mijalovsky; Maria V Pineda; Lilia Mammana; Andrea Mangano; Tomas A Orduna
Journal:  Front Med (Lausanne)       Date:  2022-07-08

10.  Relevance of HTLV-1 proviral load in asymptomatic and symptomatic patients living in endemic and non-endemic areas of Argentina.

Authors:  María Verónica Pineda; María Belén Bouzas; Mirta Remesar; Ariel Fridman; Carlos Remondegui; Lilia Mammana; Natalia Altamirano; Patricia Paradiso; Patricia Costantini; Luciana Tadey; Paula Aulicino; Andrea Mangano
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.